Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma

Clinical trial NCT00611325 · COMPLETED

Trial details

NCT number: NCT00611325
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma

Start date: 2008-05-01
Primary completion: 2009-09-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.